| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.608 | 0.014 | 0.608 | Aryl hydrocarbon receptor agonist | |||
| 0.545 | 0.015 | 0.545 | GABA C receptor rho-3 antagonist | |||
| 0.518 | 0.008 | 0.518 | Peroxidase inhibitor | |||
| 0.504 | 0.008 | 0.504 | Interleukin 2 agonist | 0.401 0.027 CID_78173372 | ||
| 0.505 | 0.009 | 0.505 | Interleukin agonist | 0.312 0.042 CID_78173372 | ||
| 0.47 | 0.006 | 0.55 | Alpha-N-acetylglucosaminidase inhibitor | 0.55 0.004 CID_78173372 | CID_78173372 | |
| 0.48 | 0.039 | 0.48 | 5 Hydroxytryptamine release inhibitor | 0.344 0.12 CID_78173372 | ||
| 0.482 | 0.042 | 0.482 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.275 0.249 CID_78173372 | ||
| 0.473 | 0.039 | 0.477 | Histamine release inhibitor | 0.477 0.037 CID_78173372 | CID_78173372 | |
| 0.47 | 0.041 | 0.47 | Calcium channel L-type activator | |||
| 0.404 | 0.037 | 0.404 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.379 | 0.019 | 0.379 | Anesthetic general | |||
| 0.351 | 0.005 | 0.351 | Carbonic anhydrase XV inhibitor | |||
| 0.335 | 0.005 | 0.335 | Ferrochelatase inhibitor | |||
| 0.349 | 0.021 | 0.349 | MAP kinase kinase 2 inhibitor | |||
| 0.339 | 0.014 | 0.339 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.25 0.043 CID_78173372 | ||
| 0.418 | 0.101 | 0.418 | Caspase 9 stimulant | 0.344 0.15 CID_78173372 | ||
| 0.326 | 0.016 | 0.326 | LIM domain kinase 1 inhibitor | |||
| 0.319 | 0.009 | 0.319 | Hexokinase inhibitor | 0.228 0.022 CID_78173372 | ||
| 0.307 | 0.026 | 0.307 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.321 | 0.044 | 0.321 | Interleukin antagonist | |||
| 0.298 | 0.021 | 0.298 | Lipocortins synthesis antagonist | |||
| 0.277 | 0.004 | 0.277 | Papain-like protease (SARS coronavirus) inhibitor | 0.131 0.058 CID_78173372 | ||
| 0.318 | 0.048 | 0.318 | Insulysin inhibitor | |||
| 0.28 | 0.013 | 0.28 | MAP kinase kinase 3 inhibitor | |||
| 0.298 | 0.033 | 0.298 | ErbB-1 antagonist | |||
| 0.287 | 0.022 | 0.287 | Neurotrophic factor enhancer | |||
| 0.293 | 0.029 | 0.293 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.287 | 0.026 | 0.287 | Neuropeptide Y2 antagonist | |||
| 0.256 | 0.009 | 0.256 | Carbonic anhydrase III inhibitor | 0.088 0.078 CID_78173372 | ||
| 0.257 | 0.013 | 0.257 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.269 | 0.028 | 0.269 | I kappa B kinase epsilon inhibitor | |||
| 0.257 | 0.022 | 0.257 | Interleukin 6 antagonist | |||
| 0.3 | 0.064 | 0.3 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.33 | 0.097 | 0.33 | Calpain 2 inhibitor | |||
| 0.255 | 0.025 | 0.255 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.242 | 0.015 | 0.242 | Death-associated protein kinase 2 inhibitor | 0.15 0.105 CID_78173372 | ||
| 0.236 | 0.01 | 0.253 | Cyclooxygenase 3 inhibitor | 0.253 0.009 CID_78173372 | CID_78173372 | |
| 0.225 | 0.007 | 0.225 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.267 | 0.053 | 0.267 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.255 | 0.047 | 0.339 | Peptidyltransferase inhibitor | 0.339 0.014 CID_78173372 | CID_78173372 | |
| 0.262 | 0.057 | 0.262 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.287 | 0.083 | 0.576 | Immunostimulant | 0.576 0.02 CID_78173372 | CID_78173372 | |
| 0.226 | 0.023 | 0.226 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.267 | 0.065 | 0.267 | Superoxide dismutase inhibitor | |||
| 0.32 | 0.118 | 0.32 | 15-Lipoxygenase inhibitor | |||
| 0.214 | 0.014 | 0.214 | Falcipain 3 inhibitor | |||
| 0.203 | 0.005 | 0.203 | Neuraminidase (influenza) inhibitor | 0.158 0.007 CID_78173372 | ||
| 0.238 | 0.039 | 0.238 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.236 | 0.038 | 0.236 | Amyloid beta precursor protein antagonist | |||
| 0.2 | 0.005 | 0.2 | NMDA receptor agonist | |||
| 0.238 | 0.044 | 0.238 | Focal adhesion kinase 2 inhibitor | |||
| 0.261 | 0.067 | 0.261 | Gastrin inhibitor | |||
| 0.22 | 0.027 | 0.22 | Anesthetic local | |||
| 0.235 | 0.044 | 0.235 | Nitric-oxide synthase stimulant | |||
| 0.194 | 0.004 | 0.194 | Neuraminidase inhibitor | 0.143 0.007 CID_78173372 | ||
| 0.212 | 0.023 | 0.212 | GABA C receptor rho-2 antagonist | |||
| 0.239 | 0.051 | 0.239 | Sigma receptor agonist | |||
| 0.22 | 0.033 | 0.22 | Phospholipase C inhibitor | 0.15 0.106 CID_78173372 | ||
| 0.191 | 0.007 | 0.191 | Toll-Like receptor 3 antagonist | |||
| 0.332 | 0.148 | 0.332 | DNA polymerase beta inhibitor | |||
| 0.208 | 0.027 | 0.331 | Catenin beta inhibitor | 0.331 0.005 CID_78173372 | CID_78173372 | |
| 0.182 | 0.003 | 0.182 | NMDA receptor glycine site agonist | |||
| 0.195 | 0.024 | 0.195 | CF transmembrane conductance regulator agonist | |||
| 0.189 | 0.018 | 0.189 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.181 0.019 CID_78173372 | ||
| 0.32 | 0.152 | 0.32 | DNA directed DNA polymerase inhibitor | |||
| 0.179 | 0.012 | 0.179 | CDK3/cyclin E inhibitor | |||
| 0.242 | 0.076 | 0.242 | Dyrk kinase inhibitor | |||
| 0.208 | 0.043 | 0.208 | Succinate dehydrogenase inhibitor | 0.154 0.105 CID_78173372 | ||
| 0.185 | 0.02 | 0.185 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.237 | 0.073 | 0.237 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.196 | 0.034 | 0.196 | M17 leucyl aminopeptidase inhibitor | |||
| 0.179 | 0.017 | 0.179 | Carbonic anhydrase XIII inhibitor | 0.122 0.029 CID_78173372 | ||
| 0.249 | 0.087 | 0.249 | Transcription factor STAT inhibitor | |||
| 0.246 | 0.085 | 0.246 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.18 | 0.019 | 0.18 | Catalase inhibitor | |||
| 0.176 | 0.016 | 0.176 | Carbonic anhydrase VI inhibitor | |||
| 0.176 | 0.017 | 0.176 | Telomerase inhibitor | |||
| 0.185 | 0.027 | 0.185 | Cathepsin H inhibitor | |||
| 0.245 | 0.087 | 0.245 | Transcription factor STAT3 inhibitor | |||
| 0.268 | 0.11 | 0.356 | Angiogenesis inhibitor | 0.356 0.068 CID_78173372 | CID_78173372 | |
| 0.225 | 0.068 | 0.225 | RNA-directed DNA polymerase inhibitor | |||
| 0.181 | 0.024 | 0.181 | GABA C receptor agonist | |||
| 0.219 | 0.065 | 0.219 | Death-associated protein kinase 3 inhibitor | |||
| 0.165 | 0.012 | 0.165 | Carbonic anhydrase V inhibitor | |||
| 0.167 | 0.015 | 0.167 | GABA C receptor rho-1 antagonist | |||
| 0.214 | 0.061 | 0.214 | TRKC antagonist | |||
| 0.189 | 0.037 | 0.189 | Hemostatic | 0.142 0.079 CID_78173372 | ||
| 0.272 | 0.122 | 0.272 | Calcium channel activator | |||
| 0.173 | 0.024 | 0.173 | 5 Hydroxytryptamine 3A agonist | |||
| 0.171 | 0.023 | 0.271 | UDP-glucose 4-epimerase inhibitor | 0.271 0.012 CID_78173372 | CID_78173372 | |
| 0.185 | 0.037 | 0.185 | Histone deacetylase SIRT1 inhibitor | |||
| 0.264 | 0.118 | 0.264 | Transcription factor NF kappa B inhibitor | 0.22 0.151 CID_78173372 | ||
| 0.206 | 0.061 | 0.206 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.153 | 0.01 | 0.153 | Carbonic anhydrase VA inhibitor | |||
| 0.165 | 0.023 | 0.165 | GABA C receptor antagonist | |||
| 0.163 | 0.022 | 0.163 | DNA repair enzyme inhibitor | 0.116 0.082 CID_78173372 | ||
| 0.18 | 0.041 | 0.18 | NADPH oxidase inhibitor | |||
| 0.201 | 0.062 | 0.201 | Growth factor agonist | |||
| 0.144 | 0.006 | 0.144 | D-Ala-D-Ala ligase inhibitor | |||
| 0.208 | 0.07 | 0.208 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.226 | 0.088 | 0.407 | DNA synthesis inhibitor | 0.407 0.021 CID_78173372 | CID_78173372 | |
| 0.141 | 0.004 | 0.141 | Dihydropteroate synthase inhibitor | |||
| 0.229 | 0.093 | 0.229 | DNA damaging | 0.169 0.146 CID_78173372 | ||
| 0.14 | 0.005 | 0.14 | Topoisomerase II beta inhibitor | |||
| 0.143 | 0.009 | 0.143 | Histone deacetylase inhibitor | |||
| 0.16 | 0.028 | 0.16 | Interleukin 8 antagonist | |||
| 0.185 | 0.053 | 0.185 | Protein kinase C nu inhibitor | |||
| 0.166 | 0.034 | 0.166 | Protein kinase (CK2) alpha inhibitor | |||
| 0.168 | 0.036 | 0.168 | Interleukin 4 antagonist | 0.132 0.069 CID_78173372 | ||
| 0.281 | 0.15 | 0.575 | Antibacterial | 0.575 0.023 CID_78173372 | CID_78173372 | |
| 0.2 | 0.069 | 0.246 | DNA methyltransferase I inhibitor | 0.246 0.049 CID_78173372 | CID_78173372 | |
| 0.18 | 0.05 | 0.18 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.145 | 0.017 | 0.145 | I kappa B kinase inhibitor | |||
| 0.212 | 0.085 | 0.493 | Cyclic AMP phosphodiesterase inhibitor | 0.493 0.007 CID_78173372 | CID_78173372 | |
| 0.137 | 0.01 | 0.137 | Carbonic anhydrase VB inhibitor | |||
| 0.16 | 0.034 | 0.16 | Interleukin 1b antagonist | |||
| 0.144 | 0.019 | 0.144 | MAP kinase kinase 1 inhibitor | |||
| 0.141 | 0.016 | 0.141 | Potassium channel (Voltage-sensitive) activator | |||
| 0.175 | 0.051 | 0.175 | CDC-like kinase 1 inhibitor | |||
| 0.166 | 0.043 | 0.166 | Neuropeptide Y1 antagonist | |||
| 0.25 | 0.127 | 0.25 | Vasodilator, peripheral | |||
| 0.202 | 0.081 | 0.202 | Anticonvulsant | |||
| 0.182 | 0.061 | 0.182 | Heat shock protein 90 alpha antagonist | |||
| 0.284 | 0.164 | 0.284 | Transcription factor inhibitor | |||
| 0.152 | 0.031 | 0.152 | Mucolytic | 0.115 0.06 CID_78173372 | ||
| 0.132 | 0.012 | 0.132 | GABA aminotransferase inhibitor | |||
| 0.195 | 0.075 | 0.195 | Non-steroidal antiinflammatory agent | |||
| 0.128 | 0.009 | 0.128 | NMDA 2C receptor antagonist | |||
| 0.217 | 0.098 | 0.217 | Calpain inhibitor | |||
| 0.193 | 0.08 | 0.193 | Histone acetyltransferase inhibitor | |||
| 0.132 | 0.02 | 0.132 | Lanosterol 14 alpha demethylase inhibitor | 0.1 0.055 CID_78173372 | ||
| 0.171 | 0.06 | 0.171 | Neurotensin receptor agonist | |||
| 0.136 | 0.025 | 0.136 | Potassium channel activator | |||
| 0.152 | 0.042 | 0.152 | Histone deacetylase class III inhibitor | |||
| 0.131 | 0.021 | 0.131 | Glutamate (mGluR7) agonist | |||
| 0.157 | 0.048 | 0.157 | Toll-Like receptor 2 antagonist | |||
| 0.174 | 0.065 | 0.174 | ATPase inhibitor | 0.148 0.105 CID_78173372 | ||
| 0.123 | 0.014 | 0.123 | Alcohol oxidase inhibitor | |||
| 0.16 | 0.051 | 0.16 | Interleukin 1 antagonist | |||
| 0.112 | 0.004 | 0.112 | Dihydroorotate oxidase inhibitor | |||
| 0.17 | 0.062 | 0.17 | Cytidine deaminase inhibitor | |||
| 0.192 | 0.084 | 0.192 | Clk dual-specificity kinase inhibitor | |||
| 0.118 | 0.011 | 0.118 | Secretase beta inhibitor | |||
| 0.229 | 0.123 | 0.229 | 12-Lipoxygenase inhibitor | |||
| 0.157 | 0.051 | 0.157 | Adenylate cyclase stimulant | |||
| 0.161 | 0.056 | 0.161 | Toll-Like receptor 9 antagonist | |||
| 0.148 | 0.042 | 0.148 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.161 | 0.055 | 0.161 | Cell wall synthesis inhibitor | 0.131 0.085 CID_78173372 | ||
| 0.144 | 0.039 | 0.144 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.147 | 0.045 | 0.147 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.174 | 0.072 | 0.174 | Tumour necrosis factor antagonist | |||
| 0.111 | 0.01 | 0.111 | I kappa B kinase 2 inhibitor | |||
| 0.107 | 0.007 | 0.107 | Histone deacetylase class I inhibitor | |||
| 0.131 | 0.033 | 0.131 | Acetylcholine release stimulant | |||
| 0.16 | 0.061 | 0.16 | Protein kinase stimulant | 0.114 0.099 CID_78173372 | ||
| 0.177 | 0.08 | 0.177 | CDC-like kinase 4 inhibitor | |||
| 0.119 | 0.023 | 0.119 | Glutamate release inhibitor | |||
| 0.175 | 0.08 | 0.175 | CDC-like kinase 2 inhibitor | |||
| 0.185 | 0.089 | 0.185 | Psychostimulant | |||
| 0.114 | 0.02 | 0.114 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.124 | 0.03 | 0.124 | Protein kinase C zeta inhibitor | |||
| 0.125 | 0.032 | 0.125 | Electrolyte absorption antagonist | |||
| 0.147 | 0.054 | 0.147 | Heat shock protein 70 antagonist | 0.131 0.118 CID_78173372 | ||
| 0.129 | 0.037 | 0.129 | Adenylate kinase inhibitor | 0.117 0.046 CID_78173372 | ||
| 0.183 | 0.091 | 0.232 | DNA methylase inhibitor | 0.232 0.059 CID_78173372 | CID_78173372 | |
| 0.096 | 0.004 | 0.096 | Neuraminidase (Influenza A) inhibitor | 0.076 0.005 CID_78173372 | ||
| 0.099 | 0.008 | 0.099 | Cyclin D1 inhibitor | |||
| 0.197 | 0.106 | 0.197 | Aldehyde oxidase inhibitor | |||
| 0.1 | 0.011 | 0.191 | Carbonic anhydrase XIV inhibitor | 0.191 0.004 CID_78173372 | CID_78173372 | |
| 0.14 | 0.052 | 0.14 | Adenylate cyclase inhibitor | |||
| 0.11 | 0.022 | 0.11 | Adenosine A3 receptor antagonist | 0.093 0.03 CID_78173372 | ||
| 0.131 | 0.043 | 0.131 | Transcription factor STAT6 inhibitor | |||
| 0.131 | 0.044 | 0.164 | Expectorant | 0.164 0.03 CID_78173372 | CID_78173372 | |
| 0.108 | 0.022 | 0.108 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.16 | 0.074 | 0.16 | Polo-like kinase-3 inhibitor | |||
| 0.138 | 0.053 | 0.271 | Alkylator | 0.271 0.014 CID_78173372 | CID_78173372 | |
| 0.123 | 0.039 | 0.123 | CDC-like kinase 3 inhibitor | |||
| 0.111 | 0.027 | 0.111 | NMDA 2 receptor antagonist | |||
| 0.102 | 0.018 | 0.102 | Biliverdin reductase inhibitor | 0.079 0.027 CID_78173372 | ||
| 0.263 | 0.18 | 0.263 | Alpha-glucosidase inhibitor | 0.259 0.182 CID_78173372 | ||
| 0.114 | 0.032 | 0.124 | NADH dehydrogenase inhibitor | 0.124 0.026 CID_78173372 | CID_78173372 | |
| 0.23 | 0.147 | 0.23 | Apoptosis antagonist | |||
| 0.099 | 0.017 | 0.099 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.093 | 0.012 | 0.12 | Factor IXa inhibitor | 0.12 0.006 CID_78173372 | CID_78173372 | |
| 0.178 | 0.098 | 0.178 | Insulin sensitizer | |||
| 0.149 | 0.068 | 0.149 | Protein kinase (CK1) gamma inhibitor | |||
| 0.105 | 0.025 | 0.105 | Histone deacetylase SIRT2 inhibitor | |||
| 0.138 | 0.059 | 0.138 | MAP kinase kinase inhibitor | |||
| 0.085 | 0.006 | 0.085 | AICAR transformylase inhibitor | |||
| 0.106 | 0.027 | 0.2 | Glycine receptor antagonist | 0.2 0.004 CID_78173372 | CID_78173372 | |
| 0.095 | 0.018 | 0.095 | Potassium channel (ATP-sensitive) blocker | |||
| 0.118 | 0.041 | 0.118 | Anabolic | |||
| 0.138 | 0.061 | 0.138 | Death-associated protein kinase 1 inhibitor | |||
| 0.199 | 0.122 | 0.199 | 5 Hydroxytryptamine release stimulant | |||
| 0.123 | 0.046 | 0.123 | Protein kinase (CK2) inhibitor | |||
| 0.082 | 0.005 | 0.082 | Immunoglobulin Fc receptor antagonist | |||
| 0.143 | 0.068 | 0.143 | Cytokine production inhibitor | |||
| 0.094 | 0.019 | 0.094 | Purinergic P2X1 antagonist | 0.064 0.039 CID_78173372 | ||
| 0.093 | 0.019 | 0.093 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.088 | 0.014 | 0.088 | Histone deacetylase SIRT3 inhibitor | |||
| 0.107 | 0.033 | 0.107 | Porphobilinogen synthase inhibitor | |||
| 0.144 | 0.071 | 0.144 | Vascular endothelial growth factor 3 antagonist | |||
| 0.088 | 0.015 | 0.088 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.149 | 0.076 | 0.149 | Heat shock protein 90 antagonist | |||
| 0.156 | 0.083 | 0.156 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.081 | 0.008 | 0.081 | Sodium/calcium exchanger inhibitor | |||
| 0.133 | 0.061 | 0.133 | Nav1.3 sodium channel blocker | |||
| 0.167 | 0.095 | 0.167 | MAP kinase kinase 5 inhibitor | |||
| 0.129 | 0.058 | 0.129 | Beta amyloid protein antagonist | |||
| 0.08 | 0.009 | 0.08 | CDK5/p25 inhibitor | |||
| 0.136 | 0.066 | 0.136 | Toll-Like receptor antagonist | |||
| 0.082 | 0.012 | 0.082 | CD45 antagonist | |||
| 0.086 | 0.017 | 0.086 | NMDA 2A receptor antagonist | |||
| 0.074 | 0.006 | 0.074 | Diamine oxidase inhibitor | |||
| 0.12 | 0.052 | 0.12 | Protein kinase C gamma inhibitor | |||
| 0.079 | 0.011 | 0.079 | Carbonic anhydrase IV inhibitor | |||
| 0.073 | 0.005 | 0.073 | Cyclin E2 inhibitor | |||
| 0.14 | 0.073 | 0.14 | Ca2+-transporting ATPase inhibitor | |||
| 0.075 | 0.009 | 0.075 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.115 | 0.05 | 0.115 | Urease inhibitor | |||
| 0.09 | 0.025 | 0.09 | GABA B receptor agonist | |||
| 0.11 | 0.046 | 0.11 | Nitric-oxide synthase inhibitor | |||
| 0.106 | 0.043 | 0.109 | Triose-phosphate isomerase inhibitor | 0.109 0.04 CID_78173372 | CID_78173372 | |
| 0.085 | 0.023 | 0.189 | Carbonic anhydrase I inhibitor | 0.189 0.007 CID_78173372 | CID_78173372 | |
| 0.089 | 0.027 | 0.089 | MAP kinase kinase 7 inhibitor | |||
| 0.119 | 0.058 | 0.119 | Photosensitizer | |||
| 0.091 | 0.03 | 0.223 | Carbonic anhydrase inhibitor | 0.223 0.008 CID_78173372 | CID_78173372 | |
| 0.107 | 0.046 | 0.107 | Alcohol dehydrogenase inhibitor | |||
| 0.098 | 0.038 | 0.098 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.11 | 0.05 | 0.11 | MAP kinase 8 inhibitor | |||
| 0.104 | 0.044 | 0.104 | NMDA receptor antagonist | |||
| 0.149 | 0.09 | 0.149 | Arachidonic acid antagonist | |||
| 0.068 | 0.009 | 0.068 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.097 | 0.038 | 0.097 | Myeloperoxidase inhibitor | |||
| 0.114 | 0.056 | 0.114 | Aminopeptidase B inhibitor | |||
| 0.092 | 0.035 | 0.092 | Glutamate dehydrogenase inhibitor | 0.08 0.045 CID_78173372 | ||
| 0.079 | 0.022 | 0.079 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.112 | 0.055 | 0.112 | DOPA decarboxylase inhibitor | |||
| 0.064 | 0.007 | 0.064 | Nerve growth factor antagonist | |||
| 0.106 | 0.05 | 0.106 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.081 | 0.025 | 0.183 | Carbonic anhydrase II inhibitor | 0.183 0.007 CID_78173372 | CID_78173372 | |
| 0.086 | 0.03 | 0.086 | Cyclin E inhibitor | |||
| 0.062 | 0.007 | 0.062 | Glutamate (mGluR8) agonist | |||
| 0.079 | 0.025 | 0.079 | Glutamate (mGluR6) antagonist | |||
| 0.147 | 0.093 | 0.147 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.108 | 0.054 | 0.108 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.076 | 0.022 | 0.076 | Transcription factor RelA inhibitor | |||
| 0.075 | 0.021 | 0.075 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.128 | 0.075 | 0.128 | Nav1.2 sodium channel blocker | |||
| 0.067 | 0.014 | 0.128 | Heparanase inhibitor | 0.128 0.003 CID_78173372 | CID_78173372 | |
| 0.08 | 0.027 | 0.099 | Carbonic anhydrase IX inhibitor | 0.099 0.02 CID_78173372 | CID_78173372 | |
| 0.078 | 0.025 | 0.078 | Beta 3 adrenoreceptor antagonist | |||
| 0.068 | 0.016 | 0.068 | Carbonic anhydrase VII inhibitor | |||
| 0.062 | 0.01 | 0.062 | Potassium channel KCNQ activator | |||
| 0.062 | 0.01 | 0.062 | Delayed rectifier potassium channel activator | |||
| 0.068 | 0.016 | 0.068 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.09 | 0.038 | 0.09 | Interferon agonist | |||
| 0.104 | 0.052 | 0.104 | Potassium channel (Ca-activated) activator | |||
| 0.09 | 0.038 | 0.09 | Rho-associated kinase I inhibitor | |||
| 0.088 | 0.037 | 0.088 | Histidine decarboxylase inhibitor | |||
| 0.135 | 0.085 | 0.135 | Pregnane X receptor agonist | |||
| 0.164 | 0.114 | 0.372 | Angiogenesis stimulant | 0.372 0.027 CID_78173372 | CID_78173372 | |
| 0.068 | 0.019 | 0.068 | Adenosine A2b receptor antagonist | |||
| 0.074 | 0.025 | 0.074 | Heat shock protein 90 beta antagonist | |||
| 0.108 | 0.059 | 0.108 | MAO A inhibitor | |||
| 0.082 | 0.036 | 0.082 | Glycine receptor agonist | |||
| 0.062 | 0.017 | 0.062 | Factor VIIa inhibitor | |||
| 0.066 | 0.021 | 0.066 | Epithelial sodium channel blocker | |||
| 0.11 | 0.066 | 0.11 | Cystathionine beta-synthase inhibitor | |||
| 0.102 | 0.057 | 0.102 | Creatine kinase inhibitor | |||
| 0.205 | 0.161 | 0.205 | Cholesterol antagonist | 0.204 0.161 CID_78173372 | ||
| 0.111 | 0.068 | 0.111 | Monophenol monooxygenase inhibitor | |||
| 0.06 | 0.016 | 0.06 | Dihydroorotase inhibitor | |||
| 0.049 | 0.006 | 0.049 | NMDA receptor glycine site antagonist | |||
| 0.065 | 0.022 | 0.065 | DNA helicase inhibitor | |||
| 0.127 | 0.085 | 0.127 | Nav1.6 sodium channel blocker | |||
| 0.199 | 0.157 | 0.199 | Prostaglandin dehydrogenase inhibitor | |||
| 0.053 | 0.011 | 0.053 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.09 | 0.049 | 0.09 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.124 | 0.082 | 0.124 | Alkaline phosphatase inhibitor | |||
| 0.133 | 0.091 | 0.133 | Thiol protease inhibitor | |||
| 0.091 | 0.05 | 0.091 | Bcr-Abl kinase inhibitor | |||
| 0.067 | 0.026 | 0.067 | Cyclin A1 inhibitor | |||
| 0.069 | 0.029 | 0.118 | Carbonic anhydrase XII inhibitor | 0.118 0.017 CID_78173372 | CID_78173372 | |
| 0.093 | 0.054 | 0.093 | Pim-3 kinase inhibitor | |||
| 0.054 | 0.015 | 0.054 | Dihydrofolate reductase inhibitor | |||
| 0.056 | 0.017 | 0.056 | Cytokine production stimulant | |||
| 0.26 | 0.221 | 0.26 | MAP kinase 1 inhibitor | |||
| 0.06 | 0.021 | 0.06 | Phosphodiesterase 7A inhibitor | |||
| 0.067 | 0.028 | 0.067 | Sphingosine kinase inhibitor | |||
| 0.131 | 0.093 | 0.322 | Diuretic | 0.322 0.019 CID_78173372 | CID_78173372 | |
| 0.087 | 0.049 | 0.087 | Acetylcholine nicotinic agonist | |||
| 0.066 | 0.029 | 0.066 | Botulinum neurotoxin type A inhibitor | |||
| 0.165 | 0.128 | 0.165 | Antiamyloidogenic | |||
| 0.069 | 0.034 | 0.069 | Adenosine A1 receptor antagonist | |||
| 0.085 | 0.05 | 0.085 | CC chemokine 5 receptor agonist | |||
| 0.126 | 0.092 | 0.126 | Aurora-C kinase inhibitor | |||
| 0.054 | 0.02 | 0.054 | Benzodiazepine antagonist | |||
| 0.055 | 0.021 | 0.055 | Adenylate cyclase 1 inhibitor | |||
| 0.09 | 0.056 | 0.09 | Histamine N-methyltransferase inhibitor | |||
| 0.067 | 0.033 | 0.067 | Phosphodiesterase 1C inhibitor | |||
| 0.069 | 0.036 | 0.069 | Interferon inducer | |||
| 0.072 | 0.039 | 0.072 | Adenosine A2 receptor antagonist | |||
| 0.09 | 0.056 | 0.09 | Bromodomain-containing protein 2 inhibitor | |||
| 0.089 | 0.056 | 0.089 | Androgen antagonist | |||
| 0.057 | 0.024 | 0.057 | Potassium channel (Inward rectifier) activator | |||
| 0.128 | 0.096 | 0.128 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.049 | 0.017 | 0.049 | Histone deacetylase 9 inhibitor | |||
| 0.109 | 0.077 | 0.124 | Caspase 3 inhibitor | 0.124 0.054 CID_78173372 | CID_78173372 | |
| 0.063 | 0.031 | 0.063 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.054 | 0.023 | 0.054 | Potassium channel (ATP-sensitive) activator | |||
| 0.034 | 0.004 | 0.034 | Neuraminidase (Influenza B) inhibitor | 0.023 0.01 CID_78173372 | ||
| 0.068 | 0.037 | 0.068 | Phosphodiesterase VII inhibitor | |||
| 0.063 | 0.033 | 0.063 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.098 | 0.068 | 0.098 | MAP kinase kinase kinase inhibitor | |||
| 0.083 | 0.053 | 0.083 | Thioredoxin reductase inhibitor | |||
| 0.068 | 0.038 | 0.068 | Adenosine A2a receptor antagonist | |||
| 0.048 | 0.019 | 0.048 | Histone deacetylase 7 inhibitor | |||
| 0.042 | 0.013 | 0.042 | Histone deacetylase 1 inhibitor | |||
| 0.052 | 0.023 | 0.052 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.037 | 0.009 | 0.037 | Purinergic P2Y15 antagonist | |||
| 0.099 | 0.071 | 0.099 | Mediator release inhibitor | |||
| 0.084 | 0.055 | 0.084 | Estrogen-related receptor beta agonist | |||
| 0.102 | 0.074 | 0.102 | Polo-like kinase-4 inhibitor | |||
| 0.05 | 0.022 | 0.05 | Histamine H2 receptor agonist | |||
| 0.051 | 0.024 | 0.051 | Purinergic P2X4 antagonist | |||
| 0.077 | 0.05 | 0.077 | Protein kinase B gamma inhibitor | |||
| 0.079 | 0.051 | 0.079 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.044 | 0.018 | 0.044 | Potassium channel Kv1.1 blocker | |||
| 0.063 | 0.037 | 0.063 | Carbonic anhydrase stimulant | |||
| 0.043 | 0.017 | 0.043 | Histone deacetylase 2 inhibitor | |||
| 0.061 | 0.035 | 0.061 | Ryanodine receptor antagonist | |||
| 0.083 | 0.058 | 0.083 | Histamine H2 receptor antagonist | |||
| 0.063 | 0.038 | 0.063 | Beta 2 adrenoreceptor agonist | |||
| 0.057 | 0.032 | 0.057 | Lysine-specific demethylase 1A inhibitor | |||
| 0.029 | 0.005 | 0.029 | Factor XIII inhibitor | |||
| 0.064 | 0.039 | 0.064 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.093 | 0.068 | 0.093 | Sphingomyelinase inhibitor | |||
| 0.073 | 0.049 | 0.073 | Aminopeptidase I inhibitor | |||
| 0.085 | 0.06 | 0.085 | Hematopoietic | |||
| 0.092 | 0.068 | 0.092 | Bile acid receptor antagonist | |||
| 0.048 | 0.025 | 0.048 | Glutamate (mGluR group III) agonist | |||
| 0.05 | 0.027 | 0.05 | Thymidylate synthase inhibitor | |||
| 0.057 | 0.034 | 0.057 | Cyclin E1 inhibitor | |||
| 0.044 | 0.021 | 0.044 | AMPA 4 receptor antagonist | |||
| 0.13 | 0.108 | 0.13 | MAP kinase 3 inhibitor | |||
| 0.065 | 0.043 | 0.065 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.112 | 0.09 | 0.112 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.048 | 0.026 | 0.048 | NMDA receptor subunit 3B antagonist | |||
| 0.142 | 0.12 | 0.142 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.105 | 0.083 | 0.105 | TRKA antagonist | |||
| 0.121 | 0.1 | 0.121 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.051 | 0.03 | 0.051 | AMPA receptor antagonist | |||
| 0.068 | 0.047 | 0.068 | Glutamate (mGluR7) antagonist | |||
| 0.035 | 0.016 | 0.035 | Epoxide hydrolase 1 inhibitor | |||
| 0.028 | 0.009 | 0.028 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.113 | 0.094 | 0.113 | Tyrosine-protein kinase receptor antagonist | |||
| 0.08 | 0.061 | 0.08 | Glutathione S-transferase inhibitor | |||
| 0.035 | 0.017 | 0.035 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.108 | 0.09 | 0.108 | Amylase inhibitor | |||
| 0.189 | 0.171 | 0.189 | Thyroid hormone antagonist | |||
| 0.043 | 0.025 | 0.043 | Sphingosine kinase 1 inhibitor | |||
| 0.043 | 0.026 | 0.043 | Kainate receptor antagonist | |||
| 0.057 | 0.039 | 0.057 | Argininosuccinate synthase inhibitor | |||
| 0.036 | 0.019 | 0.036 | Adenosine uptake inhibitor | |||
| 0.027 | 0.01 | 0.027 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.039 | 0.022 | 0.039 | Integrin alpha2 antagonist | |||
| 0.023 | 0.007 | 0.023 | Carbonic anhydrase VIII inhibitor | |||
| 0.023 | 0.007 | 0.023 | Carbonic anhydrase X inhibitor | |||
| 0.035 | 0.02 | 0.035 | Melatonin 1 agonist | |||
| 0.05 | 0.034 | 0.05 | Potassium channel (Inward rectifier) blocker | |||
| 0.04 | 0.025 | 0.04 | Vascular adhesion protein 1 inhibitor | |||
| 0.049 | 0.034 | 0.049 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.031 | 0.016 | 0.031 | Thrombin receptor antagonist | |||
| 0.108 | 0.093 | 0.108 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.05 | 0.036 | 0.05 | Beta 2 adrenoreceptor antagonist | |||
| 0.184 | 0.17 | 0.184 | Thyroid hormone beta antagonist | |||
| 0.018 | 0.004 | 0.018 | Carbonic anhydrase XI inhibitor | |||
| 0.046 | 0.032 | 0.173 | Phosphorylase inhibitor | 0.173 0.006 CID_78173372 | CID_78173372 | |
| 0.116 | 0.102 | 0.116 | Activin receptor-like kinase 2 inhibitor | |||
| 0.053 | 0.04 | 0.053 | Maillard reaction inhibitor | |||
| 0.09 | 0.076 | 0.09 | Phosphodiesterase 6D inhibitor | |||
| 0.022 | 0.008 | 0.022 | Estrogen-related receptor gamma agonist | |||
| 0.23 | 0.217 | 0.23 | MAP kinase kinase 6 inhibitor | |||
| 0.047 | 0.034 | 0.047 | Urokinase inhibitor | |||
| 0.077 | 0.064 | 0.077 | Neuropeptide Y antagonist | |||
| 0.087 | 0.074 | 0.087 | MAP kinase 9 inhibitor | |||
| 0.022 | 0.009 | 0.022 | Alpha 2c adrenoreceptor agonist | |||
| 0.084 | 0.072 | 0.084 | Thioredoxin inhibitor | |||
| 0.03 | 0.018 | 0.03 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.041 | 0.029 | 0.041 | Histone deacetylase 8 inhibitor | |||
| 0.028 | 0.016 | 0.028 | Integrin alpha2beta1 antagonist | |||
| 0.1 | 0.088 | 0.1 | Proteasome inhibitor | |||
| 0.031 | 0.019 | 0.031 | AMPA 3 receptor antagonist | |||
| 0.049 | 0.038 | 0.049 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.071 | 0.06 | 0.071 | Topoisomerase II alpha inhibitor | |||
| 0.026 | 0.016 | 0.026 | Histone deacetylase 3 inhibitor | |||
| 0.093 | 0.083 | 0.093 | Toll-Like receptor 4 antagonist | |||
| 0.029 | 0.019 | 0.029 | MAP3K8 inhibitor | |||
| 0.084 | 0.074 | 0.084 | Polo-like kinase-1 inhibitor | |||
| 0.049 | 0.04 | 0.049 | mTOR inhibitor | |||
| 0.023 | 0.014 | 0.023 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.037 | 0.028 | 0.037 | NMDA receptor subunit 3A antagonist | |||
| 0.015 | 0.006 | 0.015 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.034 | 0.025 | 0.034 | Phosphoglycerate kinase inhibitor | |||
| 0.042 | 0.033 | 0.042 | Geranyltranstransferase inhibitor | |||
| 0.018 | 0.009 | 0.022 | Adenosine A2 receptor agonist | 0.022 0.007 CID_78173372 | CID_78173372 | |
| 0.026 | 0.017 | 0.026 | Complement factor 1s inhibitor | |||
| 0.028 | 0.02 | 0.028 | Estrogen-related receptor gamma antagonist | |||
| 0.032 | 0.024 | 0.032 | Melatonin agonist | |||
| 0.032 | 0.025 | 0.032 | Purinergic P2Y2 antagonist | |||
| 0.096 | 0.089 | 0.096 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.017 | 0.01 | 0.017 | CDK2/cyclin A3 inhibitor | |||
| 0.091 | 0.084 | 0.091 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.018 | 0.012 | 0.018 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.029 | 0.023 | 0.029 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.098 | 0.092 | 0.098 | MAO inhibitor | |||
| 0.018 | 0.012 | 0.018 | Nicotinic acid receptor 1 antagonist | |||
| 0.095 | 0.09 | 0.095 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.027 | 0.021 | 0.027 | Melatonin antagonist | |||
| 0.126 | 0.12 | 0.137 | Interferon gamma antagonist | 0.137 0.098 CID_78173372 | CID_78173372 | |
| 0.031 | 0.026 | 0.031 | Melatonin 2 agonist | |||
| 0.095 | 0.089 | 0.095 | Abl kinase inhibitor | |||
| 0.078 | 0.073 | 0.078 | mTOR complex 2 inhibitor | |||
| 0.032 | 0.027 | 0.032 | Melatonin receptor 1A agonist | |||
| 0.052 | 0.047 | 0.052 | MAP kinase kinase 9 inhibitor | |||
| 0.037 | 0.032 | 0.037 | Membrane dipeptidase inhibitor | |||
| 0.073 | 0.068 | 0.073 | Adrenaline agonist | |||
| 0.064 | 0.059 | 0.064 | Amidase inhibitor | |||
| 0.038 | 0.034 | 0.038 | Plasmepsin II inhibitor | |||
| 0.049 | 0.046 | 0.049 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.145 | 0.141 | 0.145 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.032 | 0.029 | 0.032 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.063 | 0.06 | 0.063 | I kappa B kinase 1 inhibitor | |||
| 0.01 | 0.007 | 0.01 | Angiotensin AT2 receptor agonist | |||
| 0.042 | 0.039 | 0.042 | Adenosine deaminase inhibitor | |||
| 0.134 | 0.131 | 0.134 | Pyruvate kinase inhibitor | |||
| 0.036 | 0.034 | 0.036 | MAP3K5 inhibitor | |||
| 0.053 | 0.051 | 0.053 | Androgen agonist | |||
| 0.085 | 0.084 | 0.085 | Interleukin 12 antagonist | |||
| 0.078 | 0.076 | 0.078 | T cell inhibitor | |||
| 0.192 | 0.191 | 0.192 | Beta lactamase inhibitor | |||
| 0.007 | 0.006 | 0.007 | DNA topoisomerase III inhibitor | |||
| 0.058 | 0.058 | 0.079 | Phosphofructokinase-1 inhibitor | 0.079 0.042 CID_78173372 | CID_78173372 | |
| 0.014 | 0.016 | 0.046 | Ileal bile acid transport inhibitor | 0.046 0.004 CID_78173372 | CID_78173372 | |
| 0.047 | 0.051 | 0.077 | Alpha-mannosidase inhibitor | 0.077 0.013 CID_78173372 | CID_78173372 | |
| 0.184 | 0.199 | 0.262 | Antithrombotic | 0.262 0.117 CID_78173372 | CID_78173372 | |
| 0.035 | 0.052 | 0.072 | Mannosidase inhibitor | 0.072 0.011 CID_78173372 | CID_78173372 | |
| 0.013 | 0.031 | 0.028 | Adenosine kinase inhibitor | 0.028 0.011 CID_78173372 | CID_78173372 | |
| 0.169 | 0.203 | 0.201 | Immunomodulator | 0.201 0.164 CID_78173372 | CID_78173372 | |
| 0.025 | 0.075 | 0.041 | Antimetabolite | 0.041 0.04 CID_78173372 | CID_78173372 | |
| 0.07 | 0.124 | 0.18 | Topoisomerase II inhibitor | 0.18 0.038 CID_78173372 | CID_78173372 | |
| 0.038 | 0.096 | 0.079 | Glucosylceramidase inhibitor | 0.079 0.016 CID_78173372 | CID_78173372 | |
| 0.064 | 0.124 | 0.091 | Transcription factor NF kappa B stimulant | 0.091 0.049 CID_78173372 | CID_78173372 | |
| 0.032 | 0.095 | 0.261 | Selectin antagonist | 0.261 0.008 CID_78173372 | CID_78173372 | |
| 0.066 | 0.133 | 0.14 | DNA intercalator | 0.14 0.047 CID_78173372 | CID_78173372 | |
| 0.068 | 0.144 | 0.112 | AMP-activated protein kinase stimulant | 0.112 0.056 CID_78173372 | CID_78173372 | |
| 0.04 | 0.126 | 0.06 | Adenine nucleotide translocase inhibitor | 0.06 0.028 CID_78173372 | CID_78173372 | |
| 0.113 | 0.21 | 0.192 | Spasmolytic | 0.192 0.126 CID_78173372 | CID_78173372 | |
| 0.007 | 0.122 | 0.022 | Adenosine A1 receptor agonist | 0.022 0.019 CID_78173372 | CID_78173372 | |
| 0.059 | 0.179 | 0.183 | Beta glucuronidase inhibitor | 0.183 0.015 CID_78173372 | CID_78173372 | |
| 0.02 | 0.142 | 0.044 | Antibiotic Aminoglycoside-like | 0.044 0.018 CID_78173372 | CID_78173372 | |
| 0.069 | 0.197 | 0.106 | Cell adhesion inhibitor | 0.106 0.078 CID_78173372 | CID_78173372 | |
| 0.007 | 0.151 | 0.038 | Sodium/glucose cotransporter 2 inhibitor | 0.038 0.009 CID_78173372 | CID_78173372 | |
| 0.009 | 0.157 | 0.049 | Sodium/glucose cotransporter inhibitor | 0.049 0.005 CID_78173372 | CID_78173372 | |
| 0.055 | 0.211 | 0.44 | Lipid peroxidase inhibitor | 0.44 0.008 CID_78173372 | CID_78173372 | |
| 0.046 | 0.241 | 0.149 | DNA polymerase I inhibitor | 0.149 0.05 CID_78173372 | CID_78173372 | |
| 0.106 | 0.325 | 0.382 | Immunosuppressant | 0.382 0.071 CID_78173372 | CID_78173372 | |
| 0.144 | 0.372 | 0.348 | Apoptosis agonist | 0.348 0.14 CID_78173372 | CID_78173372 | |
| 0.039 | 0.285 | 0.167 | Thrombolytic | 0.167 0.07 CID_78173372 | CID_78173372 | |
| 0.01 | 0.281 | 0.11 | Antineoplastic antibiotic | 0.11 0.042 CID_78173372 | CID_78173372 | |
| 0.022 | 0.319 | 0.191 | Topoisomerase I inhibitor | 0.191 0.029 CID_78173372 | CID_78173372 | |
| 0.063 | 0.366 | 0.288 | Antioxidant | 0.288 0.066 CID_78173372 | CID_78173372 | |
| 0.051 | 0.373 | 0.179 | Platelet adhesion inhibitor | 0.179 0.083 CID_78173372 | CID_78173372 | |
| 0.051 | 0.374 | 0.236 | Free radical scavenger | 0.236 0.075 CID_78173372 | CID_78173372 | |
| 0.088 | 0.429 | 0.14 | CC chemokine 6 receptor antagonist | 0.14 0.04 CID_78173372 | CID_78173372 | |
| 0.053 | 0.409 | 0.21 | Hepatoprotectant | 0.21 0.059 CID_78173372 | CID_78173372 | |
| 0.026 | 0.529 | 0.054 | Lipocortins synthesis agonist | 0.054 0.052 CID_78173372 | CID_78173372 | |
| 0.047 | 0.566 | 0.203 | Hypoglycemic | 0.203 0.11 CID_78173372 | CID_78173372 | |
| 0.063 | 0.637 | 0.416 | Antiinflammatory | 0.416 0.129 CID_78173372 | CID_78173372 | |
| 0.023 | 0.619 | 0.134 | Nitric oxide antagonist | 0.134 0.114 CID_78173372 | CID_78173372 | |
| 0.017 | 0.81 | 0.615 | Cyclophilin D inhibitor | 0.615 0.025 CID_78173372 | CID_78173372 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |